Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Tango Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 46 | +46 |
| Shares | 0 | 65.5M | +65.5M |
| Value | $0 | $844.9M | +$844.9M |
New holders (46)
Institutions that held Tango Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (0)
Institutions that held Tango Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.